Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hewlett Packard Enterprise Co (HPE) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

Hewlett Packard Enterprise CoTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Hewlett Packard Enterprise Co vs uniQure N.V. Ordinary Shares — how do they compare? Hewlett Packard Enterprise Co trades at $60.94 (market cap $83.78B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: Hewlett Packard Enterprise Co is far larger — about 57.8× uniQure N.V. Ordinary Shares's market cap, and Hewlett Packard Enterprise Co pays a 0.9% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hewlett Packard Enterprise Co for 34 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

HPEQURE
Market Cap
$83.78B$1.45B
Volume
21,753,3703,323,243
Sector
TechnologyHealth
52-Week High
$73.46$70.59
52-Week Low
$20.01$9.03
Typical Hold Time
34 Days0 Days
Enterprise Value
$97.80B$707.46M
Dividend Yield
0.9%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hewlett Packard Enterprise Co

HPE stock trades at $68.80, down 2.13% today but remains near recent highs driven by strong AI infrastructure demand. The company has beaten earnings expectations for three consecutive quarters, with Q2 2026 EPS of $1.11 significantly exceeding the $0.932 forecast. Technical indicators show a bullish trend with support at $68 and resistance at $72, while valuation metrics include a P/E of 35.47 and P/S of 2.32. Recent news highlights a $1.2 billion AI server order from Vultr and raised revenue guidance for 2026.

HPE presents a compelling growth story fueled by AI infrastructure expansion, with analyst consensus pointing to 45% buy ratings and a $70 price target. Key risks include elevated valuation multiples and execution challenges in integrating recent acquisitions. The stock's 160% year-over-year rally suggests much optimism is priced in, requiring continued strong execution to justify further upside.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HPE
23% Buy77% Sell
Avg holding period · 34 Days
QURE
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Hewlett Packard Enterprise Co

Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.

Read more on HPE →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →